Treatment of bone and joint infections caused by Enterobacter cloacae with a fluoroquinolone-cotrimoxazole combination

被引:8
作者
Cisse, Hawa [1 ]
Vernet-Garnier, Veronique [2 ]
Hentzien, Maxime [1 ]
Bajolet, Odile [3 ]
Lebrun, Delphine [4 ]
Bonnet, Morgane [5 ]
Ohl, Xavier [6 ]
Diallo, Saidou [6 ]
Bani-Sadr, Firouze [1 ]
机构
[1] Reims Teaching Hosp, Dept Internal Med & Infect Dis, Reims, France
[2] Reims Teaching Hosp, Dept Bacteriol, Reims, France
[3] Reims Teaching Hosp, Dept Hyg, Reims, France
[4] Manchester Hosp, Dept Internal Med & Infect Dis, Charleville Mezieres, France
[5] Reims Teaching Hosp, Dept Pharm, Reims, France
[6] Reims Teaching Hosp, Dept Orthopaed Surg, Reims, France
关键词
Bone infection; Enterobacter spp; Enterobacter cloacae; Fluoroquinolone-cotrimoxazole combination; Fluoroquinolone; Cotrimoxazole; GRAM-NEGATIVE BACILLI; RISK-FACTORS; TRIMETHOPRIM; OSTEOMYELITIS; RIFAMPIN; THERAPY;
D O I
10.1016/j.ijantimicag.2019.05.010
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Although the frequency of bone and joint infections caused by Enterobacter spp. is increasing, studies regarding the optimal antibiotic therapy are scarce. The objective of this retrospective study was to assess the clinical outcomes and safety of a fluoroquinolone-cotrimoxazole combination for the treatment of bone and joint infections caused by Enterobacter cloacae. Between 2010 and 2017, 30 patients with bone and joint infections caused by E. cloacae were treated with a fluoroquinolone-cotrimoxazole combination for 8-12 weeks. There were 26 cases (87%) of infection of an internal fixation device, two cases (6.6%) of pseudarthrosis with chronic osteomyelitis, and two cases (6.6%) of infection of knee and ankle prosthetic devices. The cure rate of the fluoroquinolone-cotrimoxazole combination was 80% by intention-to-treat analysis, with a mean follow-up of 29.3 +/- 19.1 months. The fluoroquinolone-cotrimoxazole combination for 8-12 weeks is effective for the treatment of bone and joint infections caused by E. cloacae. (C) 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:245 / 248
页数:4
相关论文
共 50 条
  • [31] Intravenous fosfomycin for the treatment of patients with bone and joint infections: a review
    Tsegka, Katerina G.
    Voulgaris, Georgios L.
    Kyriakidou, Margarita
    Kapaskelis, Anastasios
    Falagas, Matthew E.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (01) : 33 - 43
  • [32] Oral antibiotic treatment of staphylococcal bone and joint infections in adults
    Kim, Baek-Nam
    Kim, Eu Suk
    Oh, Myoung-Don
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (02) : 309 - 322
  • [33] Efficacy and safety of clindamycin-based treatment for bone and joint infections: a cohort study
    Courjon, J.
    Demonchy, E.
    Cua, E.
    Bernard, E.
    Roger, P. -M.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2017, 36 (12) : 2513 - 2518
  • [34] Simplifying the treatment of acute bacterial bone and joint infections in children
    Paakkonen, Markus
    Peltola, Heikki
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (12) : 1125 - 1131
  • [35] Fluoroquinolone Versus Nonfluoroquinolone Treatment of Bloodstream Infections Caused by Chromosomally Mediated AmpC-Producing Enterobacteriaceae
    Gunter, Sarah Grace
    Barber, Katie E.
    Wagner, Jamie L.
    Stover, Kayla R.
    ANTIBIOTICS-BASEL, 2020, 9 (06): : 1 - 9
  • [36] Antibiotic treatment of Gram-positive bone and joint infections
    Darley, ESR
    MacGowan, AP
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (06) : 928 - 935
  • [37] Is Long-term Oral Therapy for Treatment of Bone and Joint Infections Ready for Prime Time?
    Seidelman, Jessica
    Sexton, Daniel J.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E2589 - E2591
  • [38] Antimicrobial Treatment Options for Multidrug Resistant Gram-Negative Pathogens in Bone and Joint Infections
    Tsilika, Maria
    Ntziora, Fotinie
    Giannitsioti, Efthymia
    PATHOGENS, 2025, 14 (02):
  • [39] Bone and joint infections caused by mucormycetes: A challenging osteoarticular mycosis of the twenty-first century
    Taj-Aldeen, Saad J.
    Gamaletsou, Maria N.
    Rammaert, Blandine
    Sipsas, Nikolaos V.
    Zeller, Valerie
    Roilides, Emmanuel
    Kontoyiannis, Dimitrios P.
    Henry, Michael
    Petraitis, Vidmantas
    Moriyama, Brad
    Denning, David W.
    Lortholary, Olivier
    Walsh, Thomas J.
    MEDICAL MYCOLOGY, 2017, 55 (07) : 691 - 704
  • [40] High Rates of Treatment Failure and Amputation in Modular Endoprosthesis Prosthetic Joint Infections Caused by Fungal Infections With Candida
    Gonzalez, Marcos R.
    Clunk, Marilee J.
    Acosta, Jose I.
    Bedi, Angad D. S.
    Karczewski, Daniel
    Lozano-Calderon, Santiago A.
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2024, 482 (07) : 1232 - 1242